 Sudipta Panja
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crystallins | 3 | 2025 | 59 | 1.900 |
Why?
| | Lysine | 3 | 2025 | 286 | 1.720 |
Why?
| | Lens, Crystalline | 3 | 2024 | 122 | 1.660 |
Why?
| | Presbyopia | 2 | 2023 | 14 | 1.620 |
Why?
| | Nanoparticles | 8 | 2025 | 375 | 1.570 |
Why?
| | Polyesters | 4 | 2021 | 71 | 1.390 |
Why?
| | Prodrugs | 2 | 2025 | 48 | 1.110 |
Why?
| | Polymers | 5 | 2025 | 477 | 1.040 |
Why?
| | Glyoxal | 1 | 2025 | 14 | 0.940 |
Why?
| | Pyruvaldehyde | 1 | 2025 | 43 | 0.920 |
Why?
| | Glycation End Products, Advanced | 1 | 2025 | 76 | 0.900 |
Why?
| | Deoxycytidine | 1 | 2025 | 165 | 0.870 |
Why?
| | Cysteine | 1 | 2025 | 195 | 0.860 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2022 | 14 | 0.810 |
Why?
| | Pancreatic Neoplasms | 3 | 2025 | 881 | 0.780 |
Why?
| | Sulfhydryl Compounds | 1 | 2024 | 187 | 0.770 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2025 | 270 | 0.760 |
Why?
| | Elastomers | 1 | 2021 | 25 | 0.750 |
Why?
| | Drug Carriers | 4 | 2022 | 119 | 0.720 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 184 | 0.720 |
Why?
| | Liposomes | 3 | 2025 | 171 | 0.670 |
Why?
| | Amyloid beta-Peptides | 1 | 2022 | 211 | 0.670 |
Why?
| | Lecithins | 1 | 2019 | 5 | 0.640 |
Why?
| | Caseins | 1 | 2019 | 18 | 0.640 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2019 | 77 | 0.630 |
Why?
| | Drug Delivery Systems | 4 | 2022 | 333 | 0.620 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2053 | 0.610 |
Why?
| | Macromolecular Substances | 1 | 2019 | 216 | 0.610 |
Why?
| | Bacterial Infections | 1 | 2019 | 235 | 0.560 |
Why?
| | Muramidase | 1 | 2016 | 77 | 0.500 |
Why?
| | Cell Membrane | 1 | 2019 | 732 | 0.500 |
Why?
| | Doxorubicin | 1 | 2015 | 328 | 0.430 |
Why?
| | Silanes | 1 | 2013 | 19 | 0.430 |
Why?
| | Solubility | 3 | 2023 | 232 | 0.420 |
Why?
| | Bacteria | 1 | 2019 | 812 | 0.410 |
Why?
| | Acetylation | 2 | 2024 | 244 | 0.400 |
Why?
| | RNA, Small Interfering | 3 | 2024 | 591 | 0.400 |
Why?
| | Disulfides | 2 | 2023 | 97 | 0.400 |
Why?
| | Acute Kidney Injury | 3 | 2024 | 790 | 0.360 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 424 | 0.350 |
Why?
| | Animals | 14 | 2025 | 35307 | 0.340 |
Why?
| | Tandem Mass Spectrometry | 2 | 2023 | 523 | 0.330 |
Why?
| | Water | 2 | 2023 | 440 | 0.320 |
Why?
| | Reperfusion Injury | 2 | 2022 | 272 | 0.320 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1702 | 0.320 |
Why?
| | Mice | 7 | 2025 | 16915 | 0.260 |
Why?
| | Lipids | 3 | 2025 | 625 | 0.250 |
Why?
| | Humans | 23 | 2025 | 129248 | 0.240 |
Why?
| | Alkylation | 1 | 2025 | 24 | 0.240 |
Why?
| | Rilpivirine | 1 | 2025 | 7 | 0.240 |
Why?
| | Inulin | 1 | 2024 | 7 | 0.230 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.230 |
Why?
| | Receptors, CCR5 | 1 | 2025 | 57 | 0.230 |
Why?
| | Dystrophin | 1 | 2024 | 34 | 0.230 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2015 | 81 | 0.230 |
Why?
| | Acetyl Coenzyme A | 1 | 2024 | 5 | 0.230 |
Why?
| | Receptors, CXCR4 | 1 | 2024 | 83 | 0.230 |
Why?
| | Theranostic Nanomedicine | 1 | 2024 | 12 | 0.220 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 131 | 0.210 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 509 | 0.210 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5439 | 0.210 |
Why?
| | Mice, Nude | 1 | 2025 | 682 | 0.210 |
Why?
| | Gene Transfer Techniques | 1 | 2024 | 161 | 0.210 |
Why?
| | Cell Survival | 3 | 2015 | 1074 | 0.210 |
Why?
| | Protein Isoforms | 1 | 2024 | 389 | 0.210 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2022 | 32 | 0.200 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2022 | 17 | 0.200 |
Why?
| | HeLa Cells | 2 | 2015 | 611 | 0.200 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 610 | 0.200 |
Why?
| | Benzoquinones | 1 | 2022 | 48 | 0.200 |
Why?
| | NAD | 1 | 2022 | 75 | 0.190 |
Why?
| | Genetic Therapy | 1 | 2024 | 288 | 0.190 |
Why?
| | Heterocyclic Compounds | 1 | 2022 | 18 | 0.190 |
Why?
| | Chitosan | 1 | 2022 | 32 | 0.190 |
Why?
| | Nucleic Acids | 1 | 2022 | 60 | 0.190 |
Why?
| | Protein Binding | 4 | 2024 | 2120 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 1 | 2024 | 454 | 0.180 |
Why?
| | Spectrometry, Fluorescence | 2 | 2019 | 163 | 0.180 |
Why?
| | Cell Movement | 1 | 2025 | 944 | 0.170 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 108 | 0.170 |
Why?
| | Fluorocarbons | 1 | 2022 | 109 | 0.170 |
Why?
| | Cell Line, Tumor | 2 | 2025 | 3201 | 0.170 |
Why?
| | Binding Sites | 3 | 2023 | 1249 | 0.170 |
Why?
| | Styrenes | 1 | 2019 | 4 | 0.160 |
Why?
| | Pyrans | 1 | 2019 | 5 | 0.160 |
Why?
| | Tissue Scaffolds | 1 | 2021 | 201 | 0.160 |
Why?
| | Thermodynamics | 3 | 2016 | 406 | 0.160 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2016 | 84 | 0.160 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 265 | 0.160 |
Why?
| | Micelles | 2 | 2015 | 37 | 0.150 |
Why?
| | Molecular Docking Simulation | 2 | 2016 | 108 | 0.150 |
Why?
| | HIV-1 | 1 | 2025 | 837 | 0.150 |
Why?
| | Biocompatible Materials | 1 | 2021 | 388 | 0.140 |
Why?
| | Particle Size | 1 | 2019 | 352 | 0.140 |
Why?
| | Protein Domains | 3 | 2024 | 253 | 0.140 |
Why?
| | Tissue Engineering | 1 | 2021 | 388 | 0.140 |
Why?
| | Cell Proliferation | 1 | 2025 | 2374 | 0.140 |
Why?
| | Tartrazine | 1 | 2016 | 1 | 0.130 |
Why?
| | Calorimetry | 1 | 2016 | 66 | 0.130 |
Why?
| | Circular Dichroism | 1 | 2016 | 147 | 0.130 |
Why?
| | Static Electricity | 1 | 2016 | 116 | 0.130 |
Why?
| | Thermogravimetry | 1 | 2015 | 5 | 0.130 |
Why?
| | Chickens | 1 | 2016 | 189 | 0.120 |
Why?
| | Magnetic Fields | 1 | 2015 | 22 | 0.120 |
Why?
| | Magnetics | 1 | 2015 | 43 | 0.120 |
Why?
| | Urethane | 1 | 2015 | 41 | 0.120 |
Why?
| | Stilbenes | 1 | 2015 | 36 | 0.120 |
Why?
| | X-Ray Diffraction | 1 | 2015 | 94 | 0.120 |
Why?
| | Protein Structure, Secondary | 1 | 2016 | 340 | 0.120 |
Why?
| | Endocytosis | 1 | 2015 | 163 | 0.110 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 63 | 0.110 |
Why?
| | Surface Properties | 1 | 2015 | 397 | 0.110 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 398 | 0.110 |
Why?
| | Propylamines | 1 | 2013 | 11 | 0.110 |
Why?
| | Aged | 2 | 2023 | 22032 | 0.110 |
Why?
| | Blood Proteins | 1 | 2015 | 244 | 0.110 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 136 | 0.100 |
Why?
| | Molecular Structure | 1 | 2013 | 478 | 0.100 |
Why?
| | Polyamines | 2 | 2022 | 39 | 0.100 |
Why?
| | Mutation | 1 | 2022 | 3710 | 0.090 |
Why?
| | Neoplasms | 2 | 2024 | 2449 | 0.090 |
Why?
| | Kidney | 3 | 2024 | 1385 | 0.090 |
Why?
| | Polyethylene Glycols | 1 | 2015 | 587 | 0.090 |
Why?
| | HIV Infections | 1 | 2025 | 2721 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 941 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2342 | 0.080 |
Why?
| | Ligands | 2 | 2025 | 621 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2021 | 841 | 0.060 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 89 | 0.050 |
Why?
| | Receptors, Virus | 1 | 2023 | 83 | 0.050 |
Why?
| | Chloroquine | 1 | 2022 | 51 | 0.050 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.050 |
Why?
| | Polyelectrolytes | 1 | 2022 | 15 | 0.050 |
Why?
| | Spermine | 1 | 2022 | 28 | 0.050 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2022 | 22 | 0.050 |
Why?
| | Virus Replication | 1 | 2025 | 450 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 52 | 0.050 |
Why?
| | Transition Temperature | 1 | 2021 | 27 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2022 | 315 | 0.050 |
Why?
| | Protein Stability | 1 | 2021 | 162 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2022 | 185 | 0.040 |
Why?
| | Administration, Oral | 1 | 2022 | 785 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 272 | 0.040 |
Why?
| | Male | 3 | 2024 | 63501 | 0.040 |
Why?
| | Precision Medicine | 1 | 2024 | 386 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2022 | 214 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 696 | 0.040 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 754 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2021 | 1304 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 631 | 0.040 |
Why?
| | Macrophages | 1 | 2025 | 1484 | 0.030 |
Why?
| | Adult | 1 | 2019 | 35495 | 0.030 |
Why?
| | Female | 2 | 2022 | 68543 | 0.030 |
Why?
| | Hydrogen Bonding | 1 | 2015 | 149 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 97 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2063 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 541 | 0.030 |
Why?
| | Temperature | 1 | 2015 | 634 | 0.020 |
Why?
| | Cattle | 1 | 2014 | 977 | 0.020 |
Why?
| | Protein Conformation | 1 | 2014 | 861 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2779 | 0.020 |
Why?
| | Insulin | 1 | 2015 | 2325 | 0.010 |
Why?
|
|
Panja's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|